Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images.
Reshape Biotech has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in April 2024.
Reshape Biotech's investors include Y Combinator, ACME Capital, Astanor Ventures, R7 Partners, FundersClub.
Reshape Biotech is headquartered in Kongens Lyngby, Denmark.
Reshape Biotech builds lab robots that automate the everyday tasks of microbiologists, from filling plates to analyzing images.
Reshape Biotech is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reshape Biotech — Funding & Investors." VCBacked, April 9, 2024, https://www.vcbacked.co/company/reshape-biotech. Accessed September 14, 2026.
VCBacked. (2024). Reshape Biotech — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/reshape-biotech
{{cite web |title=Reshape Biotech — Funding & Investors |url=https://www.vcbacked.co/company/reshape-biotech |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated